These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30891142)

  • 1. Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists.
    Duan JJ; Lu Z; Jiang B; Stachura S; Weigelt CA; Sack JS; Khan J; Ruzanov M; Galella MA; Wu DR; Yarde M; Shen DR; Shuster DJ; Borowski V; Xie JH; Zhang L; Vanteru S; Gupta AK; Mathur A; Zhao Q; Foster W; Salter-Cid LM; Carter PH; Dhar TGM
    ACS Med Chem Lett; 2019 Mar; 10(3):367-373. PubMed ID: 30891142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists.
    Lu Z; Duan JJ; Xiao H; Neels J; Wu DR; Weigelt CA; Sack JS; Khan J; Ruzanov M; An Y; Yarde M; Karmakar A; Vishwakrishnan S; Baratam V; Shankarappa H; Vanteru S; Babu V; Basha M; Kumar Gupta A; Kumaravel S; Mathur A; Zhao Q; Salter-Cid LM; Carter PH; Murali Dhar TG
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2265-2269. PubMed ID: 31257087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists.
    Duan JJ; Jiang B; Lu Z; Stachura S; Weigelt CA; Sack JS; Khan J; Ruzanov M; Wu DR; Yarde M; Shen DR; Zhao Q; Salter-Cid LM; Carter PH; Murali Dhar TG
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127441. PubMed ID: 32736080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists.
    Jiang B; Duan JJ; Stachura S; Karmakar A; Hemagiri H; Raut DK; Gupta AK; Weigelt CA; Khan J; Sack JS; Wu DR; Yarde M; Shen DR; Galella MA; Mathur A; Zhao Q; Salter-Cid LM; Carter PH; Dhar TGM
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127392. PubMed ID: 32738966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.
    Kono M; Ochida A; Oda T; Imada T; Banno Y; Taya N; Masada S; Kawamoto T; Yonemori K; Nara Y; Fukase Y; Yukawa T; Tokuhara H; Skene R; Sang BC; Hoffman ID; Snell GP; Uga K; Shibata A; Igaki K; Nakamura Y; Nakagawa H; Tsuchimori N; Yamasaki M; Shirai J; Yamamoto S
    J Med Chem; 2018 Apr; 61(7):2973-2988. PubMed ID: 29510038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.
    Cherney RJ; Cornelius LAM; Srivastava A; Weigelt CA; Marcoux D; Duan JJ; Shi Q; Batt DG; Liu Q; Yip S; Wu DR; Ruzanov M; Sack J; Khan J; Wang J; Yarde M; Cvijic ME; Mathur A; Li S; Shuster D; Khandelwal P; Borowski V; Xie J; Obermeier M; Fura A; Stefanski K; Cornelius G; Tino JA; Macor JE; Salter-Cid L; Denton R; Zhao Q; Carter PH; Dhar TGM
    ACS Med Chem Lett; 2020 Jun; 11(6):1221-1227. PubMed ID: 32551004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists - Exploring C6 and C8 SAR using late-stage functionalization.
    Shi Q; Xiao Z; Yang MG; Marcoux D; Cherney RJ; Yip S; Li P; Wu DR; Weigelt CA; Sack J; Khan J; Ruzanov M; Wang J; Yarde M; Ellen Cvijic M; Li S; Shuster DJ; Xie J; Sherry T; Obermeier M; Fura A; Stefanski K; Cornelius G; Chacko S; Shu YZ; Khandelwal P; Hynes J; Tino JA; Salter-Cid L; Denton R; Zhao Q; Dhar TGM
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127521. PubMed ID: 32882417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy.
    Marcoux D; Duan JJ; Shi Q; Cherney RJ; Srivastava AS; Cornelius L; Batt DG; Liu Q; Beaudoin-Bertrand M; Weigelt CA; Khandelwal P; Vishwakrishnan S; Selvakumar K; Karmakar A; Gupta AK; Basha M; Ramlingam S; Manjunath N; Vanteru S; Karmakar S; Maddala N; Vetrichelvan M; Gupta A; Rampulla RA; Mathur A; Yip S; Li P; Wu DR; Khan J; Ruzanov M; Sack JS; Wang J; Yarde M; Cvijic ME; Li S; Shuster DJ; Borowski V; Xie JH; McIntyre KW; Obermeier MT; Fura A; Stefanski K; Cornelius G; Hynes J; Tino JA; Macor JE; Salter-Cid L; Denton R; Zhao Q; Carter PH; Dhar TGM
    J Med Chem; 2019 Nov; 62(21):9931-9946. PubMed ID: 31638797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds.
    Shirai J; Tomata Y; Kono M; Ochida A; Fukase Y; Sato A; Masada S; Kawamoto T; Yonemori K; Koyama R; Nakagawa H; Nakayama M; Uga K; Shibata A; Koga K; Okui T; Shirasaki M; Skene R; Sang B; Hoffman I; Lane W; Fujitani Y; Yamasaki M; Yamamoto S
    Bioorg Med Chem; 2018 Jan; 26(2):483-500. PubMed ID: 29262987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of [1,2,4]Triazolo[1,5-
    Nakajima R; Oono H; Sugiyama S; Matsueda Y; Ida T; Kakuda S; Hirata J; Baba A; Makino A; Matsuyama R; White RD; Wurz RΡ; Shin Y; Min X; Guzman-Perez A; Wang Z; Symons A; Singh SK; Mothe SR; Belyakov S; Chakrabarti A; Shuto S
    ACS Med Chem Lett; 2020 Apr; 11(4):528-534. PubMed ID: 32292560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
    Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
    J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives.
    Kono M; Oda T; Tawada M; Imada T; Banno Y; Taya N; Kawamoto T; Tokuhara H; Tomata Y; Ishii N; Ochida A; Fukase Y; Yukawa T; Fukumoto S; Watanabe H; Uga K; Shibata A; Nakagawa H; Shirasaki M; Fujitani Y; Yamasaki M; Shirai J; Yamamoto S
    Bioorg Med Chem; 2018 Jan; 26(2):470-482. PubMed ID: 29258712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity.
    Gong H; Weinstein DS; Lu Z; Duan JJ; Stachura S; Haque L; Karmakar A; Hemagiri H; Raut DK; Gupta AK; Khan J; Camac D; Sack JS; Pudzianowski A; Wu DR; Yarde M; Shen DR; Borowski V; Xie JH; Sun H; D'Arienzo C; Dabros M; Galella MA; Wang F; Weigelt CA; Zhao Q; Foster W; Somerville JE; Salter-Cid LM; Barrish JC; Carter PH; Dhar TGM
    Bioorg Med Chem Lett; 2018 Jan; 28(2):85-93. PubMed ID: 29233651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis.
    Liu Q; Xiao HY; Batt DG; Xiao Z; Zhu Y; Yang MG; Li N; Yip S; Li P; Sun D; Wu DR; Ruzanov M; Sack JS; Weigelt CA; Wang J; Li S; Shuster DJ; Xie JH; Song Y; Sherry T; Obermeier MT; Fura A; Stefanski K; Cornelius G; Chacko S; Khandelwal P; Dudhgaonkar S; Rudra A; Nagar J; Murali V; Govindarajan A; Denton R; Zhao Q; Meanwell NA; Borzilleri R; Dhar TGM
    ACS Med Chem Lett; 2021 May; 12(5):827-835. PubMed ID: 34055233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
    Wang Y; Yang T; Liu Q; Ma Y; Yang L; Zhou L; Xiang Z; Cheng Z; Lu S; Orband-Miller LA; Zhang W; Wu Q; Zhang K; Li Y; Xiang JN; Elliott JD; Leung S; Ren F; Lin X
    Bioorg Med Chem; 2015 Sep; 23(17):5293-302. PubMed ID: 26277758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy.
    Gao Z; Hurst WJ; Hall D; Hartung R; Reynolds W; Kang J; Nagorny R; Hendrix JA; George PG
    Bioorg Med Chem; 2015 Feb; 23(3):429-38. PubMed ID: 25577710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists.
    Hintermann S; Guntermann C; Mattes H; Carcache DA; Wagner J; Vulpetti A; Billich A; Dawson J; Kaupmann K; Kallen J; Stringer R; Orain D
    ChemMedChem; 2016 Dec; 11(24):2640-2648. PubMed ID: 27902884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of carbazole carboxamides as novel RORγt inverse agonists.
    Huang Y; Yu M; Sun N; Tang T; Yu F; Song X; Xie Q; Fu W; Shao L; Wang Y
    Eur J Med Chem; 2018 Mar; 148():465-476. PubMed ID: 29477887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate.
    Anselm L; Banner DW; Benz J; Zbinden KG; Himber J; Hilpert H; Huber W; Kuhn B; Mary JL; Otteneder MB; Panday N; Ricklin F; Stahl M; Thomi S; Haap W
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5313-9. PubMed ID: 20650636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of
    Zhang H; Lapointe BT; Anthony N; Azevedo R; Cals J; Correll CC; Daniels M; Deshmukh S; van Eenenaam H; Ferguson H; Hegde LG; Karstens WJ; Maclean J; Miller JR; Moy LY; Simov V; Nagpal S; Oubrie A; Palte RL; Parthasarathy G; Sciammetta N; van der Stelt M; Woodhouse JD; Trotter BW; Barr K
    ACS Med Chem Lett; 2020 Feb; 11(2):114-119. PubMed ID: 32071676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.